STD Series: Drugs on the horizon for Hepatitis B and Hepatitis C
by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents 1. Introduction 2. Hepatitis: Causes and Symptoms 3. Pharmaceutical Industry Advancements 4. Hepatitis B Drugs under Development • Direct-acting drugs • siRNA • TDF Pro Drugs • Entry Inhibitors • Capsid Inhibitors • HBsAg Inhibitors • Antisense...Recent Articles

ELISA Sensitivity and Specificity
June 5, 2025
Sensitivity reflects a test’s ability to correctly identify individuals with a disease or condition, while…
Read more
ELISA Evolution
August 6, 2024
Key Milestones 1941 – Introduction of Immunofluorescence In 1941, Albert H. Coons and his team were the first…
Read more
ELISA: Data Analysis and Interpretation
July 25, 2024
How to Analyze ELISA: 1. Run samples in duplicates or triplicates to ensure statistical accuracy. Average the readings…
Read more
ELISA: Qualitative vs. Quantitative
July 24, 2024
ELISA plays a crucial role in various experiments, case studies, and surveys, where precise measurement and interpretation of…
Read morePopular Posts
No posts found.